siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells.

BMC Cancer · 2009 · PMC2691745 · PMID 19416503

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The MDA-MB-453 cells seemed to have a higher resistance to doxorubicin-induced apoptosis than siRNA-induced apoptosis, although the difference did not reach statistical significance (Fig. 3A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.